Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

U2AF1 mutations alter splice site recognition in hematological malignancies.

Genome research | 2015

Whole-exome sequencing studies have identified common mutations affecting genes encoding components of the RNA splicing machinery in hematological malignancies. Here, we sought to determine how mutations affecting the 3' splice site recognition factor U2AF1 alter its normal role in RNA splicing. We find that U2AF1 mutations influence the similarity of splicing programs in leukemias, but do not give rise to widespread splicing failure. U2AF1 mutations cause differential splicing of hundreds of genes, affecting biological pathways such as DNA methylation (DNMT3B), X chromosome inactivation (H2AFY), the DNA damage response (ATR, FANCA), and apoptosis (CASP8). We show that U2AF1 mutations alter the preferred 3' splice site motif in patients, in cell culture, and in vitro. Mutations affecting the first and second zinc fingers give rise to different alterations in splice site preference and largely distinct downstream splicing programs. These allele-specific effects are consistent with a computationally predicted model of U2AF1 in complex with RNA. Our findings suggest that U2AF1 mutations contribute to pathogenesis by causing quantitative changes in splicing that affect diverse cellular pathways, and give insight into the normal function of U2AF1's zinc finger domains.

Pubmed ID: 25267526 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: P30 CA015704
  • Agency: NCI NIH HHS, United States
    Id: NIH/NCI P30 CA015704
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK056465
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009657
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM088277
  • Agency: PHS HHS, United States
    Id: NIH/NHLBI U01 HL099993
  • Agency: PHS HHS, United States
    Id: NIH/NIDDK P30 DK056465
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL099993
  • Agency: NCI NIH HHS, United States
    Id: T32CA009657
  • Agency: PHS HHS, United States
    Id: NIH/NIDDK K08 DK082783
  • Agency: PHS HHS, United States
    Id: NIH/NIGMS R01 GM088277
  • Agency: NIDDK NIH HHS, United States
    Id: K08 DK082783

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


MISO (tool)

RRID:SCR_003124

Probabilistic framework that quantitates the expression level of alternatively spliced genes from RNA-Seq and identifies differentially regulated isoforms or exons across samples.

View all literature mentions

K-562 (tool)

RRID:CVCL_0004

Cell line K-562 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HeLa (tool)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions